It actually is good news because it means that the study on EKC has been confirmed and he has signed on with NNVC to be their guy in Japan and negotiate a deal with big Pharma Japan. Now NNVC will have 2 big Pharma deals with the same drug. 1 in Japan and 1 here in the US.
Market Data 
Markets 
AI
